Low-Density Lipoprotein Apheresis: Principles and Indications

Seminars in Dialysis

Volumn 25, Issue 2, 2012, Pages 145-151

  Winters, Jeffrey L ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LOW DENSITY LIPOPROTEIN;

APHERESIS; ARTICLE; BLOOD; CARDIOVASCULAR DISEASE; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; HYPERLIPIDEMIA; ISOLATION AND PURIFICATION; MALE; METHODOLOGY; PATIENT SAFETY; RISK ASSESSMENT; TREATMENT OUTCOME;

BLOOD COMPONENT REMOVAL; CARDIOVASCULAR DISEASES; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERLIPIDEMIAS; LIPOPROTEINS, LDL; MALE; PATIENT SAFETY; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84858701766     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1111/j.1525-139X.2011.01025.x     Document Type: Article

References (34)

1. Szczepiorkowski ZM, Winters JL, Bandarenko N, Kim HC, Linenberger ML, Marques MB, Sarode R, Schwartz J, Weinstein R, Shaz B: Guidelines on the use of therapeutic apheresis in clinical practice - evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis. J Clin Apher 25:83-177, 2010
2. Thompson GR, Myant NB, Kilpatrick D, Oakley CM, Raphael MJ, Steiner RE: Assessment of long-term plasma exchange for familial hypercholesterolaemia. Br Heart J 43:680-688, 1980
3. Tatami R, Inoue N, Itoh H, Kishino B, Koga N, Nakashima Y, Nishide T, Okamura K, Saito Y, Teramoto T, Yasugi T, Yamamoto A, Goto Y: Regression of coronary atherosclerosis by combined LDL apheresis and lipid-lowering drug therapy in patients with familial hypercholesterolemia: a multicenter study. Atherosclerosis 95:1-13, 1992
4. Thompson GR, Miller JP, Breslow JL: Improved survival of patients with homozygous familial hypercholesterolaemia treated by plasma exchange. Br Med J 291:1671-1673, 1985
5. Stoffel W, Borberg H, Greve V: Application of specific extracorporeal removal of low density lipoprotein in familial hypercholesterolaemia. Lancet 2:1005-1007, 1981
6. Siami GA, Siami FS: Membrane plasmapheresis in the United States: a review over the last 20years. Ther Apher 5:315-320, 2001
7. Klingel R, Mausfeld P, Fassbender C, Goehlen B: Lipidfiltration - safe and effective methodology to perform lipid-apheresis. Transfus Apher Sci 30:245-254, 2004
8. Yokoyama S: Treatment of hypercholesterolemia by chemical adsorption of lipoproteins. J Clin Apher 4:66-71, 1988
9. Yamamoto A, Kojima S, Shiba-Harada M, Kawaguchi A, Hatanaka K: Assessment of the biocompatibility and long-term effect of LDL-apheresis by dextran sulfate-cellulose column. Artif Organs 16:177-181, 1992
10. Riesen WF: Experience with low-density lipoprotein apheresis by polyclonal and monoclonal anti-apolipoprotein B antibodies and by dextran sulfate cellulose. Curr Stud Hematol Blood Transfus 57:208-219, 1990
11. Mabuchi H, Michishita I, Takeda M, Fujita H, Koizumi J, Takeda R, Takada S, Oonishi M: A new low-density lipoprotein apheresis system using two dextran sulfate cellulose columns in an automated column regenerating unit (LDL continuous apheresis). Atherosclerosis 68:19-25, 1987
12. Koizumi J, Koizumi I, Uno Y, Inazu A, Kajinami K, Haraki T, Yagi K, Kamon N, Miyamoto S, Takegoshi T, Mabuchi H, Takeda R, Tani N, Takada S: Reduction of lipoprotein (a) by LDL-apheresis using a dextran sulfate cellulose column in patients with familial hypercholesterolemia. Atherosclerosis 100:65-74, 1993
13. Bambauer R, Schiel R, Latza R: Low-density lipoprotein apheresis: an overview. Ther Apher Dial 7:382-390, 2003
14. Bosch T, Schmidt B, Kleophas W, Gillen C, Otto V, Passlick-Deetjen J, Gurland HJ: LDL hemoperfusion - a new procedure for LDL apheresis: first clinical application of an LDL adsorber compatible with human whole blood. Artif Organs 21:977-981, 1997
15. Otto C, Kern P, Bambauer R, Kallert S, Schwandt P, Parhofer KG: Efficacy and safety of a new whole-blood low-density lipoprotein apheresis system (Liposorber D) in severe hypercholesterolemia. Artif Organs 27:1116-1122, 2003
16. Koziolek MJ, Henning U, Zapf A, Bramlage C, Grupp C, Armstrong VW, Strutz F, Muller GA: Retrospective analysis of long-term lipid apheresis in a single center. Ther Apher Dial 14:143-152, 2010
17. Owen HG, Brecher ME: Atypical reactions associated with use of angiotensin-converting enzyme inhibitors and apheresis. Transfusion 34:891-894, 1994
18. Tasaki H, Yamashita K, Saito Y, Bujo H, Daida H, Mabuchi H, Tominaga Y, Matsuzaki M, Fukunari K, Nakazawa R, Tsuji M, Kawade Y, Yamamoto S, Ueda Y, Takayama K: Low-density lipoprotein apheresis therapy with a direct hemoperfusion column: a Japanese multicenter clinical trial. Ther Apher Dial 10:32-41, 2006
19. Sinzinger H, Chehne F, Ferlitsch A, Oguogho A: Angiotensin receptor antagonists during dextran sulfate LDL-apheresis are safe. Thromb Res 100:43-46, 2000
20. Adamski J, Jamensky L, Ross J, Siegel DL, Sachais BS: Anaphylactoid-like reactions in a patient with hyperLp(a)lipidemia undergoing LDL apheresis with dextran sulfate adsorption and herbal therapy with the spice turmeric. J Clin Apher 25:354-357, 2010
21. Matsuda Y, Malchesky PS, Nose Y: Assessment of currently available low-density lipoprotein apheresis systems. Artif Organs 18:93-99, 1994
22. Krebs A, Krebs K, Keller F: Retrospective comparison of 5 different methods for long-term LDL-apheresis in 20 patients between 1986 and 2001. Int J Artif Organs 27:137-148, 2004
23. Bhatnagar D: Diagnosis and screening for familial hypercholesterolaemia: finding the patients, finding the genes. Ann Clin Biochem 43:441-456, 2006
24. Ueda M: Familial hypercholesterolemia. Mol Genet Metab 86:423-426, 2005
25. Soutar AK, Naoumova RP: Mechanisms of disease: genetic causes of familial hypercholesterolemia. Nat Clin Pract Cardiovasc Med 4:214-225, 2007
26. Thompson GR, HEART-UK LDL Apheresis Working Group: Recommendations for the use of LDL apheresis. Atherosclerosis 198:247-255, 2008
27. Stefanutti C, Vivenzio A, Di Giacomo S, Mazzarella B, Ferraro PM, Abbolito S: Treatment of symptomatic hyperLp(a)lipidemia with LDL-apheresis vs. usual care. Transfus Apher Sci 42:21-26, 2010
28. Thompson GR, Barbir M, Davies D, Dobral P, Gesinde M, Livingston M, Mandry P, Marais AD, Matthews S, Neuwirth C, Pottle A, le Roux C, Scullard D, Tyler C, Watkins S: Efficacy criteria and cholesterol targets for LDL apheresis. Atherosclerosis 208:317-321, 2010
29. Mabuchi H, Koizumi J, Shimzu M, Kajinami K, Miyamoto S, Ueda K, Takegoshi T: Long-term efficacy of low-density lipoprotein apheresis on coronary heart disease in familial hypercholesterolemia. Am J Cardiol 82:1489-1495, 1998
30. Matsuzaki M, Hiramori K, Imaizumi T, Kitabatake A, Hishida H, Nomura M, Fujii T, Sakuma I, Fukami K, Honda T, Ogawa H, Yamagishi M: Intravascular ultrasound evaluation of coronary plaque regression by low density lipoprotein-apheresis in familial hypercholesterolemia. J Am Coll Cardiol 40:220-227, 2002
31. Aengevaeren WRM, Kroon AA, Stalenhoef AFH, Uijen GJH, Van der Werf T: Low density lipoprotein apheresis improves regional myocardial perfusion in patients with hypercholesterolemia and extensive coronary artery disease. JACC 28:1696-1704, 1996
32. Kroon AA, van Asten WN, Stalenhoef AF: Effect of apheresis of low-density lipoprotein on peripheral vascular disease in hypercholesterolemic patients with coronary artery disease. Ann Intern Med 125:945-954, 1996
33. Park JW, Merz M, Braun P: Regression of transplant coronary artery disease during chronic low-density lipoprotein-apheresis. J Heart Lung Transplant 16:290-297, 1997
34. Parhofer KG, Geiss HC, Schwandt P: Efficacy of different low-density lipoprotein apheresis methods. Ther Apher 4:381-385, 2000